维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Risner ME"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Intravenous self-administration of phencyclidine and related compounds in the dog显示文摘	Risner ME	1982	J Pharmacol Exp Ther1982，221，3：	1
2	Efficacy of rosiglitazone in a genetically defined population with mild-to- moderate Alzheimer's disease显示文摘	RISNER ME SAUNDERS AM ALTMAN JF	2006	Pharmacogenomics J2006，6，4：	1
3	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease 显示文摘	Risner 'ME Saunders AM Altman JF	2006	Pharmacogenomics J2006，6，4：	1
4	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease显示文摘	Risner ME Saunders AM Altman JFB	2006	Pharmacogenomics J2006，4，：	1
5	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease显示文摘	Risner ME Saunders AM Ahman JF	2006	Pharmacogenomics J2006，6，4：	1
6	Efficacy of rosiglitazone in a genetically defined population with mild- to-moderate Alzheimer's disease 显示文摘	Risner ME Saunders AM Airman JF	2006	Pharmacogenomics J2006，6，4：	1
7	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease 显示文摘	Risner ME Saunders AM Altman JF	2006	Pharmacogenomics J2006，6，：	1
8	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease显示文摘	Risner ME Saunders AM Altman JFB	2006	Pharmacogenomics J2006，6，4：	1
9	The tolerability of lamotrigine in children显示文摘	Messenheimer JA Giorgi L Risner ME	2000	Drug Saf2000，22，：	1
10	Efficacy ofrosiglitazone in a genetically defined population with mild to-moderate Alzheimer's disease显示文摘	Risner ME Saunders AM Altman JF	2006	Pharmacogenomics J2006，6，：	1
11	Efficacy of rosiglitazone in a genetically defined population with mildto-moderate Alzheimer's disease 显示文摘	Risner ME Saunders AM Altman JF	2006	Pharmacogenomics J2006，6，4：	1
12	Self-administration of CNS stimulants by dog显示文摘	Risner ME Jones BE	1975	Psychopharmacologia1975，43，3：	1
13	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease 显示文摘	Risner ME Saunders AM Altman JF	2006	Pharmacogenomics J2006，6，4：	1
14	Characteristics of unlimited access to self-administered stimulant infusions in dogs显示文摘	Risner ME Jones BE	1976	Biol Psychiatry1976，11，5：	1
15	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate alzheimer's dis- ease 显示文摘	Risner ME Saunders AM Altman JF	2006	Pharmacogenomics J2006，6，4：	1
16	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease显示文摘	Risner ME Saunders AM Altman JF	2006	Pharmacogenomics J2006，6，4：	1
17	Psychostimulant self-administration by beagle dogs in a progressive-ratio paradigm显示文摘	Risner ME Silcox DL	1981	Psychopharmacology(Berl)1981，75，：	1
18	Efficacy ofrosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease显示文摘	Risner ME Saunders AM Altman JF	2006	Pharmacogenomics J2006，6，4：	1
19	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease 显示文摘	RISNER ME SAUNDERS AM ALTMAN JF	2006	Pharmacogenomics J2006，6，4：	1
20	Self-administration of CNS stimulants by dog显示文摘	Risner ME Jones BE	1975	Psychopharmacologia1975，43，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示